BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26312226)

  • 1. Botulinum toxin for the treatment of hyperfunctional lines of the forehead.
    Sunil SM; Babu BG; Deepthi S; Veerabhadrappa AC; Vadavadagi SV; Punde P
    J Int Soc Prev Community Dent; 2015; 5(4):276-82. PubMed ID: 26312226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
    Blitzer A; Binder WJ; Aviv JE; Keen MS; Brin MF
    Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):389-92. PubMed ID: 9109785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
    Bowler PJ
    J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study.
    Keen M; Blitzer A; Aviv J; Binder W; Prystowsky J; Smith H; Brin M
    Plast Reconstr Surg; 1994 Jul; 94(1):94-9. PubMed ID: 8016257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cosmetic use of botulinum toxin type B in the upper face.
    Sadick NS
    Clin Dermatol; 2004; 22(1):29-33. PubMed ID: 15158542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for the treatment of hyperfunctional lines of the face.
    Blitzer A; Brin MF; Keen MS; Aviv JE
    Arch Otolaryngol Head Neck Surg; 1993 Sep; 119(9):1018-22. PubMed ID: 8357583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
    Bulstrode NW; Grobbelaar AO
    Aesthetic Plast Surg; 2002; 26(5):356-9. PubMed ID: 12432474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
    Dubina M; Tung R; Bolotin D; Mahoney AM; Tayebi B; Sato M; Mulinari-Brenner F; Jones T; West DP; Poon E; Nodzenski M; Alam M
    J Cosmet Dermatol; 2013 Dec; 12(4):261-6. PubMed ID: 24305424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin (Botox) to enhance facial macroesthetics: a literature review.
    Dastoor SF; Misch CE; Wang HL
    J Oral Implantol; 2007; 33(3):164-71. PubMed ID: 17674683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evaluation of Use of Botulinum Toxin Type A in the Management of Dynamic Forehead Wrinkles - A Clinical Study.
    Susmita A; Kolli NN; Meka S; Chakravarthi SP; Kattimani VS; Lingamaneni KP; Shaik LS
    J Clin Diagn Res; 2016 Oct; 10(10):ZC127-ZC131. PubMed ID: 27891474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A injection for hyperfunctional facial lines.
    Keen MS; Khosh MM
    Laryngoscope; 1995 Oct; 105(10):1134-7. PubMed ID: 7564848
    [No Abstract]   [Full Text] [Related]  

  • 15. Supraciliary wrinkles and botulinum toxin A.
    Ghalamkarpour F; Robati RM; Aryanejad F; Toossi P
    Clin Exp Dermatol; 2010 Jun; 35(4):388-91. PubMed ID: 19874314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exaggeration of wrinkles after botulinum toxin injection for forehead horizontal lines.
    Kang SM; Feneran A; Kim JK; Park O; Kim JE; Won CH; Chang S; Lee MW; Choi JH; Moon KC; Youn CS; Cho S; Lee SH
    Ann Dermatol; 2011 May; 23(2):217-21. PubMed ID: 21747624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines.
    Guerrissi J; Sarkissian P
    Ann Plast Surg; 1997 Nov; 39(5):447-53. PubMed ID: 9374139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.